Diabetes Care: Muditam’s Blend of Traditional Ayurveda and Contemporary Science showing encouraging results
Integrating Holistic Practices with Cutting-Edge Research for Comprehensive Diabetes Management
Hey founders, funds, & friends 👋,
A warm welcome to the 15th edition of the “Mehtta Ventures Dubai” investment digest newsletter, your weekly news digest about startup stories across the Middle East & India, digital / business trends shaping our lives and curated venture investment opportunities.
If you are not already a subscriber, please sign up below and join several others who receive it directly in their inbox every Monday.
Imagine a world where we can press a "pause button" on biology, preserving the essence of life itself for future possibilities. This concept, often found in the corridors of science fiction, is stepping into the realm of reality thanks to Cradle Healthcare Co.
Founded by the visionary Laura Deming, a child prodigy who started her lab research at just 12 years old, alongside Hunter Davis, Cradle Healthcare is pioneering advancements in cryonics. With a fresh injection of $48 million in funding, this innovative startup is emerging from three years of stealth operation to bring futuristic science to today's medical challenges.
Cradle's Groundbreaking Applications:
Neuroscientific Research: Cryopreserving human brain tissue could revolutionize neurological studies by making rare samples readily accessible.
Organ Donation: Imagine a world without the race against time in organ transplants. By freezing organs, Cradle aims to vastly extend their viability, easing the testing and matching process.
Fighting Terminal Illness: For patients suffering from currently incurable diseases, cryonics offers a beacon of hope. Preserving their bodies could one day allow them to awaken to a cure.
While the concept of freezing and later reviving organs, or even whole bodies, might sound like the plot of a sci-fi movie, it's not as far-fetched as you might think. Techniques for preserving living tissues are already in use in fields like in vitro fertilization and have been successfully demonstrated in academic studies, such as the University of Minnesota's experiment with rat kidneys.
Cradle's current focus remains on perfecting the preservation of rodent brain tissue, where they have achieved significant milestones in maintaining the electrical activity of neurons post-thaw.
Challenges and Future Horizons: Despite the promise, challenges remain. Ice crystal formation can damage cells, and the cryoprotectants used to prevent this are often toxic. Furthermore, while Cradle is not the first to venture into cryonics— with entities like Alcor Life Extension Foundation storing over 200 humans and pets—the revival of these preserved bodies remains a hurdle yet to be overcome.
Today’s program:
Navigating the Surge in India's Diabetes Care Market: Opportunities and Challenges Ahead
Startup Deal #14: Muditam: Innovative Approach to Diabetes Reversal
And….Action!
Navigating the Surge in India's Diabetes Care Market: Opportunities and Challenges Ahead
As India grapples with the title of the "diabetes capital of the world," the nation's diabetes care market is poised for a significant expansion. According to a recent study by Redcore, the research arm of Bengaluru-based Redseer Consulting, this market is projected to soar from $17 billion in FY2021 to a staggering $60 billion over the next decade (Source: Business Standard)
A Growing Health Crisis: With 75 million individuals currently diagnosed with diabetes and an additional 200 million categorized as pre-diabetic, the urgency for effective diabetes management solutions has never been more critical. The rapid escalation of these numbers is largely attributed to poor lifestyle choices prevalent across the country.
Economic Burden of Diabetes Care: The financial impact on individuals is profound. An average Indian spends approximately Rs 11,000 annually on Type-2 diabetes care, escalating to Rs 3.5 lakh over a lifetime. As patients age, the annual cost of care can increase from Rs 6,000 in their early thirties to Rs 17,000 by the time they reach 60.
Interestingly, the economic demographics of those affected are telling: only 5% of the diabetic population earns a monthly income of Rs 80,000 or more, while a substantial 35% earn below Rs 20,000. This disparity highlights a critical need for affordable and accessible healthcare solutions.
The Need for Inclusive Healthcare Solutions: Anuj Kumar, director at RedCore, emphasizes that nearly 95% of India's diabetic population falls into the middle and low-income categories, with limited access to necessary care. "It is critical for India to identify a diabetes care solution which is affordable and comprehensive to make it a real success in the country," he stated.
Technological Innovations and Future Prospects: While new-age technological innovations like connected blood glucose monitoring devices and app-based doctor guidance have transformed diabetes care in the Western world, the adoption of such advancements in India hinges on their affordability and accessibility.
Broader Chronic Disease Market: The report also sheds light on the broader chronic disease landscape in India, with diabetes, cardiovascular disease, and hypertension leading the way. These three conditions alone represented a market size of about $35 billion in FY21 and are expected to grow nearly threefold in the next decade.
As India stands at the cusp of a healthcare transformation, the potential for innovative, cost-effective solutions in diabetes care offers a promising horizon for investors, entrepreneurs, healthcare providers and patients alike.
Startup Deal #14, Muditam: Innovative Approach to Diabetes Reversal
Industry: Healthtech
Headquarters: New Delhi, India
Fund Raise Ask: $1 million to raise ARR to $6 million
Traction: Total Net Revenue: $420K (₹3.5 Cr)
Annual Run Rate: $1M (₹8 Cr)
Customer Base: 12,000+ customers
Orders: 18,000+
Healthy Margins
Founders: Abhay Gupta (120+ years of family legacy implementing Ayurverda) and Madhur Sachdev
Business Model: B2B2C
Introduction to Muditam
Muditam operates as a revolutionary startup brand in the diabetes care sector, uniquely blending Ayurveda, modern science, and a healthy lifestyle into a cohesive treatment approach. This pioneering brand addresses the core shortcomings of traditional diabetes treatments by offering a holistic and personalized solution.
Overview of Current Diabetes Care
Current Treatment Landscape:
Medication Dependence: Traditional treatments focus primarily on suppressing symptoms through medication.
Lack of Root Cause Analysis: There is a general failure to identify and address the underlying causes of diabetes.
Increasing Costs: Patients face escalating medication dosages and costs over time.
Challenges in the Current Model
Short-term Focus: Healthcare providers concentrate on lowering blood sugar levels without addressing underlying causes.
Market Dynamics: Dominated by practitioners who emphasize medication over lifestyle changes.
Side Effects: Lifelong dependency on allopathic medicines comes with numerous side effects.
Neglect of Lifestyle Factors: Few address diabetes as the lifestyle disease that it fundamentally is.
Organ Health: There is a lack of focus on the disease's impact on vital organs until severe damage occurs.
Muditam’s Proven Approach to Diabetes Reversal
Holistic and Personalized Strategy:
Dedicated Reversal Coach: Each patient is assigned a coach to guide them through their treatment.
Continuous Monitoring: Regular checks on symptoms, blood sugar levels, and overall progress.
Deprescribing: Efforts are made to reduce medication dosage over time.
Tri-wellness Approach:
Traditional Ayurveda: Leveraging ancient practices known for treating the root causes of ailments.
Modern Science: Incorporating contemporary scientific methods to enhance the efficacy of Ayurvedic principles.
Healthy Lifestyle: Encouraging significant lifestyle and dietary changes to sustain long-term health.
Embracing Digital Health
Integration of Technology: Muditam uses digital tools to personalize and enhance the patient experience, making ancient wisdom accessible to the modern, digital-savvy generation.
Business Performance Metrics
Revenue and Customer Base:
Total Net Revenue: $420K (₹3.5 Cr)
Annual Run Rate: $1M (₹8 Cr)
Customer Base: 12,000+ customers
Orders: 18,000+
Profitability:
Gross Profit Margin: 80%
Net Profit Margin: ~9%
Customer Loyalty:
Returning Customer Rate: ~42%
Average Order Value: $30 (₹2500)
Conclusion and Outlook
Muditam's innovative approach, combining Ayurveda with modern scientific practices and a focus on lifestyle changes, positions it uniquely in the rapidly growing wellness and healthcare industry. This strategy not only addresses the root causes and complications of diabetes but also aligns with global trends towards personalized and holistic health solutions.
This deal presents a compelling opportunity to invest in a brand that is set to redefine diabetes care with a proven track record of growth and customer satisfaction.
Contact Us
For more information about this deal and other startup investment opportunities, please contact me at viniitmehta@mehttaventuresdubai.com OR book time via my scheduling link here.
Stay tuned to our newsletter for more exciting investment opportunities and industry insights and also share it with folks in your network who might be interested!
While you wait for our next newsletter, I encourage you to check out our other newsletter / streaming consulting destination: The Streaming Lab where we cover streaming insights from MENA and India.
The “Mehtta Ventures Dubai investment digest” is a weekly newsletter exploring the trends that matter to startup founders and investment professionals in the Middle East & India. If you are not already a subscriber, sign up and join several others who receive it directly in their inbox every Monday.
Interested in investing with Mehtta Ventures Dubai in MENA & India? Email me
+ We work with startups, funds, other family offices and investment banks and help them upgrade their strategies, investments and market access. Contact me here.
+ We are on the Board of Directors of Adsolut Media, Asia’s largest digital video ad network. Please get in touch if you want to advertise to build awareness or generate leads for your brand across 7 billion + impressions per month including 150+ publishers, OTTs and broadcasters in the Middle East and several more in India, APAC, Europe and the United States. Contact me here.